| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 724780 | (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 | 0.00134950525162028 | 0.31546571 |
| NSC 736081 | 4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine | 0.00134950525162028 | 0.28725066 |
| NSC 117281 | ANTINEOPLASTIC-117281 | 0.00134950525162029 | 0.3388763 |
| NSC 138780 | 8-(3-Methylbutyryloxy)diacetoxyscirpenol | 0.00134950525162029 | 0.32954509 |
| NSC 23416 | Null | 0.00134950525162029 | 0.48444165 |
| NSC 119621 | Null | 0.00142226725147591 | -0.12195767 |
| NSC 275971 | Null | 0.00142226725147591 | 0.63976844 |
| NSC 646395 | Null | 0.00142226725147591 | 0.31403004 |
| NSC 672140 | Null | 0.00142226725147591 | 0.33553244 |
| NSC 676794 | Olean-12-en-28-oic acid, 3-.beta.-(6-methyl-.beta.-D-glucopyranuronosyloxy)-, [2-O-[3-O-(D-.apio.-.beta.-D-ribofuranosy)- 4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl]-.beta.-D-xylopy | 0.00142226725147591 | -0.0014851316 |